Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

4930511J11Rik Inhibitors

Chemical inhibitors of 4930511J11Rik can act through various signaling pathways to inhibit its activity. For instance, Wortmannin and LY294002 are both PI3K inhibitors, which disrupt the AKT signaling pathway, a critical route for various cellular processes including those that may involve 4930511J11Rik. By inhibiting PI3K, these chemicals prevent the phosphorylation and activation of AKT, which is essential for downstream signaling events that promote cell survival and growth. This interruption can restrain the cellular activities associated with 4930511J11Rik. Similarly, PD98059 and U0126 target the MAPK/ERK pathway by inhibiting MEK, which is upstream of ERK. Since ERK is a kinase that phosphorylates various substrates involved in cell proliferation and differentiation, these inhibitors can thwart the pathway's ability to propagate signals that might enhance 4930511J11Rik functions.

In addition to these, SB203580 and SP600125 selectively inhibit p38 MAP kinase and JNK, respectively, which are part of the cell's response to stress signals. By blocking these kinases, the associated stress response pathways that may engage 4930511J11Rik are dampened, leading to reduced activity of the protein. Rapamycin inhibits mTOR, another kinase implicated in cell growth and proliferation, which could be critical for 4930511J11Rik's role in these processes. Src family kinases, targeted by PP2 and Dasatinib, are involved in various signaling networks, and their inhibition might disrupt pathways that engage 4930511J11Rik. Gefitinib and Erlotinib inhibit EGFR tyrosine kinase, while Lapatinib targets HER2 and EGFR, which may be involved in growth factor signaling pathways that include 4930511J11Rik. By obstructing these tyrosine kinases, the chemicals can impede the activation of downstream signaling cascades that would otherwise contribute to 4930511J11Rik's functional role in the cell. Through the disruption of these pathways, these chemical inhibitors can collectively hinder the functional activity of 4930511J11Rik within the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K which is involved in the AKT signaling pathway, leading to inhibition of 4930511J11Rik activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K affecting AKT pathway and potentially reduces 4930511J11Rik activity through this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK thereby disrupting the ERK/MAPK pathway, which can inhibit 4930511J11Rik downstream signaling.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Acts on MEK1/2 in the MAPK/ERK pathway which could lead to the functional inhibition of 4930511J11Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, potentially decreasing 4930511J11Rik activity linked to stress response signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor which can reduce 4930511J11Rik activity by altering the JNK signaling pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR that may be critical for 4930511J11Rik function related to cell growth and proliferation signals.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Src kinase inhibitor which can inhibit signaling pathways involving 4930511J11Rik.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits Src family kinases which may be part of the signaling pathways that 4930511J11Rik is involved in.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Inhibits EGFR tyrosine kinase which might be upstream of 4930511J11Rik in growth factor signaling pathways.